Predict your next investment

Venture Capital
originateventures.com

See what CB Insights has to offer

Investments

34

Portfolio Exits

3

Funds

1

About Originate Ventures

Originate Ventures is a venture capital firm with offices in Bethlehem, PA targets early stage product and services companies in Pennsylvania and surrounding regions.

Originate Ventures Headquarter Location

205 Webster Street

Bethlehem, Pennsylvania, 18015,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Originate Ventures News

Micro Interventional Devices Closes $20M Series D Financing

Mar 8, 2019

Micro Interventional Devices, Inc. (MID) , a Newton, Pa.-based company that designs, develops and commercializes proprietary, percutaneous technologies, is closing a $20m series D round of financing. The round was led by Oscor, a company that designs, develops, manufactures and markets a variety of specialized implantable devices for neuromodulation, cardiac rhythm management and structural heart disease, as well as ancillary delivery systems and accessories, with participation from Originate Ventures, LifeSciences Greenhouse of PA, Ben Franklin Venture Partners of Northeastern PA, and other existing shareholders. In this transaction, MID’s debt will convert to Series D preferred stock. In conjunction with the funding, Oscor’s CEO, Thomas Osypka, will join Micro Interventional Devices’ Board of Directors. The company intends to use the proceeds to complete its ongoing STTAR (Study of Transcatheter Tricuspid Annular Repair) Clinical Trial, which is studying MIA’s safety and efficacy in the percutaneous (less invasive) treatment of tricuspid and mitral regurgitation. In addition to the investment, MID and Oscor announced a strategic alliance that leverages each company’s capabilities to further develop and commercialize innovative solutions to structural heart disease, specifically, MID’s MIA™, Minimally Invasive Annuloplasty, technology. Under the terms of this agreement, MID acquires a non-exclusive worldwide license to Oscor’s patented catheter technology and in turn, Oscor receives exclusive manufacturing rights to MID’s MIA devices. FinSMEs 08/03/2019

Originate Ventures Investments

34 Investments

Originate Ventures has made 34 investments. Their latest investment was in Cryo Concepts as part of their Unattributed VC - II on August 8, 2019.

CBI Logo

Originate Ventures Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

8/15/2019

Unattributed VC - II

Cryo Concepts

$9M

No

1

8/14/2019

Unattributed VC

Cryo Concepts

$7.5M

Yes

1

3/7/2019

Series D

Micro Interventional Devices

$20M

No

5

11/25/2014

Series A - IV

Subscribe to see more

$99M

Subscribe to see more

10

1/29/2014

Series A - V

Subscribe to see more

$99M

Subscribe to see more

10

Date

8/15/2019

8/14/2019

3/7/2019

11/25/2014

1/29/2014

Round

Unattributed VC - II

Unattributed VC

Series D

Series A - IV

Series A - V

Company

Cryo Concepts

Cryo Concepts

Micro Interventional Devices

Subscribe to see more

Subscribe to see more

Amount

$9M

$7.5M

$20M

$99M

$99M

New?

No

Yes

No

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

1

1

5

10

10

Originate Ventures Portfolio Exits

3 Portfolio Exits

Originate Ventures has 3 portfolio exits. Their latest portfolio exit was Tabula Rasa Healthcare on September 29, 2016.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

9/29/2016

IPO

$991

1

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

Date

9/29/2016

00/00/0000

00/00/0000

Exit

IPO

Subscribe to see more

Subscribe to see more

Companies

Subscribe to see more

Subscribe to see more

Valuation

$991

Acquirer

Subscribe to see more

Subscribe to see more

Sources

1

10

10

Originate Ventures Fund History

1 Fund History

Originate Ventures has 1 fund, including Originate Growth Fund 1.

Closing Date

Fund

Fund Type

Status

Amount

Sources

Originate Growth Fund 1

Multi-Stage Venture Capital

1

Closing Date

Fund

Originate Growth Fund 1

Fund Type

Multi-Stage Venture Capital

Status

Amount

Sources

1

Originate Ventures Team

5 Team Members

Originate Ventures has 5 team members, including current Founder, Managing Partner, Glen R. Bressner.

Name

Work History

Title

Status

Glen R. Bressner

Founder, Managing Partner

Current

Glen Bressner

Founder

Current

Kerry A. Wrobel

President

Current

Eric Arnson

Managing Partner

Current

Michael Gausling

Managing Partner

Current

Name

Glen R. Bressner

Glen Bressner

Kerry A. Wrobel

Eric Arnson

Michael Gausling

Work History

Title

Founder, Managing Partner

Founder

President

Managing Partner

Managing Partner

Status

Current

Current

Current

Current

Current

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.